BCL2L11 and cancer: From the perspective of autophagy, the downregulation of BCL2L11 can improve the death threshold of cancer cells through two mechanisms, thus promoting their drug resistance: the direct inactivation of apoptotic signaling cascade and the induction of cytoprotective autophagy (Dai and Grant, 2015).